Challenging year for Sun Pharma in US as FY26 revenue falls 0.9% (Soban News)

Sun Pharma’s FY26 US revenue declines 0.9 per cent amid continued pressure in generics business despite growth in innovative medicines and specialty portfolio​Sun Pharma’s FY26 US revenue declines 0.9 per cent amid continued pressure in generics business despite growth in innovative medicines and specialty portfolio ​Latest News [ SOBAN NEWS: International and National ]